《Medicalxpress,1月13日,Preliminary research suggests SARS-CoV-2 virus less infectious within five minutes of exposure to air》

  • 来源专题:COVID-19科研动态监测
  • 编译者: YUTING
  • 发布时间:2022-01-25
  • In a study that has not yet been peer-reviewed or accepted for publication, researchers at Bristol University in the U.K. have found evidence that suggests the SARS-CoV-2 virus becomes less infectious within five minutes of exposure to air. The team has published a paper on the pre-print server MedRxiv describing tests designed to simulate the behavior of the virus after it is transmitted into the air by an infected person.

    Since the pandemic first began, health care officials have been asking people around the world to wear a mask. The main purpose of such masks for non-health-care workers is to slow the speed with which the virus is transmitted into the air as a person exhales, sneezes or coughs. The thinking has been that wearing a mask helps to protect those around an infected person. In this new effort, the researchers found evidence that suggests the virus, once transmitted into the air, has only five minutes until it starts losing its ability to infect other people. If the finding proves to be accurate, wearing a mask becomes even more important. Preventing the virus from sailing across an open space when it only has five minutes to infect someone would reduce its transmissibility drastically.

    The researchers chose a simulation method that has not been used by other researchers—instead of using Goldberg drums, they created an apparatus that generates and levitates viruses between electric rings. The virus samples are thus held in a state in which their infectiousness could be measured.

    The researchers found that its transmissibility began dropping within five minutes of exposure to the air. A closer look showed that this is because it begins to dry out and suffers a lack of carbon dioxide. They found that after 20 minutes, the transmissibility of the virus was reduced by 90 percent. They also found that more humid air slowed the loss of transmissibility, and that temperature had no impact.

    At this time, it is not yet clear how well the method matches with conditions in a natural environment. Also, the new method does not take into account ventilation, room size or the viral load of the infected person. And finally, it is still not known what level of transmissibility the virus must have in order to infect people.

  • 原文来源:https://medicalxpress.com/news/2022-01-preliminary-sars-cov-virus-infectious-minutes.html
相关报告
  • 《Medicalxpress,12月13日,Researchers develop a molecule that blocks SARS-CoV-2 infection》

    • 来源专题:COVID-19科研动态监测
    • 编译者:YUTING
    • 发布时间:2021-12-18
    • A research team at Aarhus University has developed a new molecule that attaches to the surface of SARS-CoV-2 virus particles. This attachment prevents the virus from entering human cells and spreading the infection. The newly developed molecule belongs to a class of compounds known as RNA aptamers and it is based on the same type of building blocks that are used for mRNA vaccines. This makes them much cheaper and easier to manufacture than the antibodies that are currently used to treat COVID-19 and to detect viral infection using rapid antigen tests. An aptamer is a piece of DNA or RNA that folds into a 3D structure that can recognize a specific target molecule of interest. By attaching itself to the virus surface, the RNA aptamer prevents the Spike protein from serving as a key that allows the virus to enter a cell. Hence, the RNA aptamer is not a new type of vaccine but a compound that can potentially stop the virus from spreading in the body once someone is exposed to the virus. The efficient binding to SARS-CoV-2 virus also means that the aptamer can be used to test for COVID-19 infection. "We have started testing the new aptamer in rapid tests and we expect to be able to detect very low concentrations of the virus" says Professor Jørgen Kjems from Aarhus University who is the main author of the article which has just been published in the journal PNAS. Studies in cell culture show that the aptamer works against the previous variants of coronavirus that the researchers had the opportunity to test. "Since we submitted the article for peer review, we have continued our studies and been able to show that it also recognizes the delta variant. Now we are waiting for samples of the newly identified variant, omicron, so we can test whether the aptamer also recognizes that," says Jørgen Kjems.
  • 《Medicalxpress,12月30日,Research team discovers a novel vaccine strategy to prevent SARS-CoV-2 nasal infection》

    • 来源专题:COVID-19科研动态监测
    • 编译者:YUTING
    • 发布时间:2022-01-10
    • Researchers at the Department of Microbiology and State Key Laboratory of Emerging Infectious Diseases, LKS Faculty of Medicine of The University of Hong Kong (HKUMed) have conducted a comprehensive study for identifying an effective vaccine regimen in preventing SARS-CoV-2 nasal infection. The study demonstrated that a combination of intramuscular PD1-based receptor-binding domain (RBD) DNA vaccine (PD1-RBD-DNA) prime and intranasal live attenuated influenza-based vaccine (LAIV-HK68-RBD) boost vaccination regimen induced the strongest mucosal broadly neutralizing antibodies and lung resident memory CD8 T cells, which prevented live SARS-CoV-2 nasal challenges in two animal models. The full research article is now online in the journal of EBioMedicine, published by The Lancet.